Ariola, Fidel .

HRN: 04-09-06  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/05/2025
CEFTRIAXONE 1G (VIAL)
05/05/2025
05/12/2025
IV
2g
OD
Dm Foot
Waiting Final Action 
05/05/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/05/2025
05/12/2025
IV
600mg
Q6
Dm Foot
Waiting Final Action 
05/06/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/06/2025
05/13/2025
IV
4.5 G
Q8h
Diabetic Foot
Waiting Final Action 
05/28/2025
LEVOFLOXACIN 500MG (TAB)
05/28/2025
06/03/2025
PO
500 Mg
Od
Dm Foot
Remove - Pending Acceptance
10/06/2025
CEFTRIAXONE 1G (VIAL)
10/06/2025
10/12/2025
IV
2 Grams
IV OD
Dm Foot
Waiting Final Action 
10/06/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/06/2025
10/12/2025
IV
600
Q8
Dm Foot
Waiting Final Action 
10/06/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/06/2025
10/12/2025
IV
4.5
Q8
Dm Foot Wagner 5
Waiting Final Action 
10/06/2025
CIPROFLOXACIN 500MG (TAB)
10/06/2025
10/12/2025
PO
500 Mg
Bid
Dm Foot Wagner 5
Waiting Final Action 
10/09/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/09/2025
10/16/2025
IV
1g
Q8
Sepsis Sec To DM Foot

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: